Cargando…

Commentary: Predicting blood concentration of tacrolimus in patients with autoimmune diseases using machine learning techniques based on real-world evidence

Detalles Bibliográficos
Autores principales: Zhu, Yuxiang, Wang, Xuebin, Wang, Xue, Chen, Lizhi, Wang, Zhuo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9669900/
https://www.ncbi.nlm.nih.gov/pubmed/36408265
http://dx.doi.org/10.3389/fphar.2022.1000476
_version_ 1784832229220810752
author Zhu, Yuxiang
Wang, Xuebin
Wang, Xue
Chen, Lizhi
Wang, Zhuo
author_facet Zhu, Yuxiang
Wang, Xuebin
Wang, Xue
Chen, Lizhi
Wang, Zhuo
author_sort Zhu, Yuxiang
collection PubMed
description
format Online
Article
Text
id pubmed-9669900
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-96699002022-11-18 Commentary: Predicting blood concentration of tacrolimus in patients with autoimmune diseases using machine learning techniques based on real-world evidence Zhu, Yuxiang Wang, Xuebin Wang, Xue Chen, Lizhi Wang, Zhuo Front Pharmacol Pharmacology Frontiers Media S.A. 2022-11-03 /pmc/articles/PMC9669900/ /pubmed/36408265 http://dx.doi.org/10.3389/fphar.2022.1000476 Text en Copyright © 2022 Zhu, Wang, Wang, Chen and Wang. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Zhu, Yuxiang
Wang, Xuebin
Wang, Xue
Chen, Lizhi
Wang, Zhuo
Commentary: Predicting blood concentration of tacrolimus in patients with autoimmune diseases using machine learning techniques based on real-world evidence
title Commentary: Predicting blood concentration of tacrolimus in patients with autoimmune diseases using machine learning techniques based on real-world evidence
title_full Commentary: Predicting blood concentration of tacrolimus in patients with autoimmune diseases using machine learning techniques based on real-world evidence
title_fullStr Commentary: Predicting blood concentration of tacrolimus in patients with autoimmune diseases using machine learning techniques based on real-world evidence
title_full_unstemmed Commentary: Predicting blood concentration of tacrolimus in patients with autoimmune diseases using machine learning techniques based on real-world evidence
title_short Commentary: Predicting blood concentration of tacrolimus in patients with autoimmune diseases using machine learning techniques based on real-world evidence
title_sort commentary: predicting blood concentration of tacrolimus in patients with autoimmune diseases using machine learning techniques based on real-world evidence
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9669900/
https://www.ncbi.nlm.nih.gov/pubmed/36408265
http://dx.doi.org/10.3389/fphar.2022.1000476
work_keys_str_mv AT zhuyuxiang commentarypredictingbloodconcentrationoftacrolimusinpatientswithautoimmunediseasesusingmachinelearningtechniquesbasedonrealworldevidence
AT wangxuebin commentarypredictingbloodconcentrationoftacrolimusinpatientswithautoimmunediseasesusingmachinelearningtechniquesbasedonrealworldevidence
AT wangxue commentarypredictingbloodconcentrationoftacrolimusinpatientswithautoimmunediseasesusingmachinelearningtechniquesbasedonrealworldevidence
AT chenlizhi commentarypredictingbloodconcentrationoftacrolimusinpatientswithautoimmunediseasesusingmachinelearningtechniquesbasedonrealworldevidence
AT wangzhuo commentarypredictingbloodconcentrationoftacrolimusinpatientswithautoimmunediseasesusingmachinelearningtechniquesbasedonrealworldevidence